Medical sources
Links checked: 2026-11-12
Educational material for FSP language preparation. Not official clinical guidance or a basis for clinical decisions.
These are medical reference and verification sources for educational language exercises. They are not the original sources of personal examination reports and do not imply endorsement of FSP-to-Go.
Laboratory reference values
The values below identify the learning examples and their cited reference methods. They are not universal clinical reference intervals.
Reference intervals depend on the laboratory, method, age and sex. This learning material uses the intervals from the cited sources.
Troponin and CK-MB limits are assay-specific. CK-MB mass is distinct from activity; CK-BB and CK-MM are serum electrophoresis fractions.
BNP uses an acute-heart-failure exclusion threshold. NT-proBNP uses the cited laboratory’s age-specific interval; these values are not interchangeable.
Some entries are decision limits or risk-dependent targets, not universal reference intervals. An eGFR value alone does not establish or exclude kidney disease.
The ESR interval shown applies to adults younger than 50. The source gives different limits at older ages.
Troponin T (hs) High-sensitivity troponin T
< 14 ng/L
Troponin T, hochsensitiv: Analytinformation Universitätsklinikum Bonn
Referenzbereich: Troponin T hs; Roche Cobas ECLIA
Troponin I (hs) High-sensitivity troponin I
♀ < 16 · ♂ < 34 ng/L
Troponin I (hs-TnI) – Abbott Alinity University Hospitals Birmingham NHS Foundation Trust
99th percentile: Abbott Alinity hs-TnI, sex-specific cutoffs
CK-MB (Masse) Creatine kinase MB isoenzyme (mass concentration)
♀ < 3,61 · ♂ < 4,87 ng/mL
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
MMB: CK-MB Masse, Erwachsene ab 16 J.
CK-BB Creatine kinase BB isoenzyme
0 % der Gesamt-CK
CK-Isoenzyme: Elektrophorese (30.06.2025) Universitätsklinikum Köln – Institut für Klinische Chemie
Serum: CK-BB, Elektrophorese
CK-MM Creatine kinase MM isoenzyme
97–100 % der Gesamt-CK
CK-Isoenzyme: Elektrophorese (30.06.2025) Universitätsklinikum Köln – Institut für Klinische Chemie
Serum: CK-MM, Elektrophorese
Erythrozyten Red blood cells
♂ 4,5–5,9 · ♀ 4,0–5,2 × 10⁶/µL
Kleines Blutbild und Differentialblutbild Universitätsklinikum Köln – Institut für Klinische Chemie
Erythrozyten: Männer/Frauen
Thrombozyten Platelets
150–400 × 10³/µL
Kleines Blutbild und Differentialblutbild Universitätsklinikum Köln – Institut für Klinische Chemie
Thrombozyten: Erwachsene
Leukozyten White blood cells
4,0–10,0 × 10³/µL
Untersuchungen in Vollblut, Serum, Plasma (08/2023) Klinikum Nürnberg – Institut für Klinische Chemie
Blutbild / Leukozyten: 4,0–10,0 /nl
Hämoglobin Hemoglobin
♂ 13,5–18,0 · ♀ 12,0–16,0 g/dL
Kleines Blutbild und Differentialblutbild Universitätsklinikum Köln – Institut für Klinische Chemie
Hämoglobin: Männer/Frauen
CRP C-reactive protein
< 5 mg/L
CRP: Referenzbereich im Heparin-Plasma Universitätsklinikum Köln – Institut für Klinische Chemie
Heparin-Plasma: Roche CRP-Latex-Test Gen. 3
BSG / ESR Erythrocyte sedimentation rate
♂ ≤ 15 · ♀ ≤ 20 mm/h (< 50 J.)
Leistungsverzeichnis IML (Version 8.1, 02/2026) Helios Universitätsklinikum Wuppertal – Institut für Medizinische Labordiagnostik
BSG, Seite 17: Erwachsene unter 50 J.
LDL-Cholesterin LDL cholesterol
< 100 mg/dL (Zielwert risikoadaptiert)
Cholesterol Levels: What You Need to Know U.S. National Library of Medicine – MedlinePlus
Adults ≥20 years; desirable cholesterol levels / triglycerides
HDL-Cholesterin HDL cholesterol
♂ > 40 · ♀ > 50 mg/dL
Cholesterol Levels: What You Need to Know U.S. National Library of Medicine – MedlinePlus
Adults ≥20 years; desirable cholesterol levels / triglycerides
Triglyzeride (nüchtern) Triglycerides (fasting)
< 150 mg/dL
Cholesterol Levels: What You Need to Know U.S. National Library of Medicine – MedlinePlus
Adults ≥20 years; desirable cholesterol levels / triglycerides
Gesamtcholesterin Total cholesterol
< 200 mg/dL
Cholesterol Levels: What You Need to Know U.S. National Library of Medicine – MedlinePlus
Adults ≥20 years; desirable cholesterol levels / triglycerides
Natrium (Na⁺) Sodium (Na⁺)
135–145 mmol/L
Leistungsverzeichnis (01.10.2025), Blutgasdiagnostik Universitätsklinikum Gießen und Marburg – Zentrallabor Gießen
Blutgasdiagnostik, Seite 39: Natrium, Erwachsene
Kalium (K⁺) Potassium (K⁺)
3,5–5,0 mmol/L
Leistungsverzeichnis (01.10.2025), Blutgasdiagnostik Universitätsklinikum Gießen und Marburg – Zentrallabor Gießen
Blutgasdiagnostik, Seite 39: Kalium, Erwachsene
Calcium, ionisiert (Ca²⁺) Ionized calcium (Ca²⁺)
1,12–1,32 mmol/L
Ionisiertes Calcium im Vollblut (Revision 003, 10.06.2024) Universitätsklinikum Ulm – Zentrale Einrichtung Klinische Chemie
Seite 2: ionisiertes Calcium im Vollblut, Erwachsene
Magnesium (Mg²⁺)
0,70–1,00 mmol/L
Chemie – Bloed – Magnesium: referentiewaarden OLVG Lab BV, Amsterdam
Referentiewaarden: M/V >16 jaar
Kreatinin Creatinine
♂ 0,7–1,2 · ♀ 0,5–1,0 mg/dL
Kreatinin (Jaffé) im Serum: Leistungsverzeichnis LMU Klinikum München – Institut für Laboratoriumsmedizin
Kreatinin (Jaffé) im Serum: M/W ab 14 Jahre
Harnstoff Urea
2,5–7,8 mmol/L
Urea: adult reference interval Oxford University Hospitals NHS Foundation Trust
Urea: age ≥18 years, 2.5–7.8 mmol/L
eGFR Estimated GFR
≥ 90 mL/min/1,73 m²
KDIGO 2024 Clinical Practice Guideline for CKD Kidney Disease: Improving Global Outcomes (KDIGO)
Table 2, page S137: GFR category G1 (≥90)
Quick / Prothrombinzeit Prothrombin activity (Quick) / prothrombin time
70–130 %
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
QUIC: Quick, %
aPTT Activated partial thromboplastin time
22–36 s
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
PTT: aPTT, sec
INR International normalized ratio
0,9–1,1 (ohne Antikoagulation)
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
INR: Int. norm. ratio
D-Dimere D-dimer
< 0,5 mg/L FEU (altersabhängig)
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158) National Institute for Health and Care Excellence (NICE)DDIM: D-Dimere, FEU; NICE NG158: age-adjusted threshold over 50
BNP B-type natriuretic peptide
< 100 pg/mL
Acute heart failure: diagnosis and management (CG187) National Institute for Health and Care Excellence (NICE)
Recommendation 1.2.2: BNP <100 ng/L (= pg/mL), acute setting
NT-proBNP N-terminal pro-B-type natriuretic peptide
< 125 pg/mL (ambulant, < 75 J.)
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
PROBNP: NT-proBNP, age <75 years
Glukose (nüchtern) Fasting glucose
70–99 mg/dL (3,9–5,5 mmol/L)
Diabetes Tests & Diagnosis U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Low Blood Glucose (Hypoglycemia) U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Nonpregnant fasting glucose: ≤99 mg/dL; hypoglycemia threshold <70 mg/dL
HbA1c Glycated hemoglobin (HbA1c)
< 5,7 %
Diabetes Tests & Diagnosis U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Nonpregnant adults: normal A1C <5.7%
C-Peptid (nüchtern) Fasting C-peptide
1,1–4,4 ng/mL
C-Peptid: Analytinformation (19.08.2026) Universitätsklinikum Bonn
Seite 4: C-Peptid, nüchtern
TSH Thyroid-stimulating hormone (TSH)
0,27–4,2 mU/L
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
TSH: Erwachsene ab 20 J.
Freies T3 (fT3) Free triiodothyronine (fT3)
2,0–4,4 pg/mL
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
FT3: Erwachsene ab 19 J.
Freies T4 (fT4) Free thyroxine (fT4)
0,93–1,70 ng/dL
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
FT4: Erwachsene ab 19 J.
Gesamt-T3 Total triiodothyronine (T3)
0,8–2,0 ng/mL
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
T3: Erwachsene ab 20 J.
Gesamt-T4 Total thyroxine (T4)
5,1–14,1 µg/dL
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
T4: Erwachsene ab 20 J.
ALT / GPT Alanine aminotransferase (ALT)
♂ < 50 · ♀ < 35 U/L
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
ALAT: Männer/Frauen
AST / GOT Aspartate aminotransferase (AST)
♂ < 50 · ♀ < 35 U/L
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
ASAT: Männer/Frauen
Gamma-GT (GGT) Gamma-glutamyl transferase (GGT)
♂ 0–60 · ♀ 0–40 U/L
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
GGT: Männer/Frauen
Alkalische Phosphatase (AP) Alkaline phosphatase (ALP)
♂ 40–130 · ♀ 35–105 U/L
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
ALP: Männer/Frauen ab 19 J.
Bilirubin, gesamt Total bilirubin
♂ 0–1,4 · ♀ 0–0,9 mg/dL
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
TBIL: Männer/Frauen
Albumin
35–52 g/L
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
SALB: Albumin, g/L
Lipase
13–60 U/L
Referenzbereiche (13.04.2026) Universitätsklinikum Bonn – Institut für Klinische Chemie und Klinische Pharmakologie
LIPA: Lipase, U/L
Pankreas-Amylase Pancreatic amylase
13–53 U/L
Pankreas-α-Amylase: Roche method sheet, Serum/Plasma Universitätsklinikum Köln – Institut für Klinische Chemie / Roche Diagnostics
Referenzwerte: Serum/Plasma, Männer/Frauen, 13–53 U/L
Clinical study topics
References for checking the educational medical content. Examination recollections are not clinical guidelines.
Peripheral arterial disease (PAD)
Peripheral arterial disease: diagnosis and management (CG147) National Institute for Health and Care Excellence (NICE)
Venous leg ulcer with diabetic foot
Leg ulcer infection: antimicrobial prescribing (NG152) National Institute for Health and Care Excellence (NICE)
Diabetic foot problems: prevention and management (NG19) National Institute for Health and Care Excellence (NICE)Deep vein thrombosis (DVT)
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158) National Institute for Health and Care Excellence (NICE)
Lymphomas (Hodgkin/non-Hodgkin)
Hodgkin Lymphoma Treatment (PDQ®) – Health Professional Version U.S. National Cancer Institute (NCI)
Non-Hodgkin lymphoma: diagnosis and management (NG52) National Institute for Health and Care Excellence (NICE)Tuberculosis
Tuberculosis (NG33) National Institute for Health and Care Excellence (NICE)
Lung cancer (bronchial carcinoma)
Lung cancer: diagnosis and management (NG122) National Institute for Health and Care Excellence (NICE)
Pneumonia
Pneumonia: diagnosis and management (NG250) National Institute for Health and Care Excellence (NICE)
COVID-19
COVID-19 rapid guideline: managing COVID-19 (NG191) National Institute for Health and Care Excellence (NICE)
Bronchial asthma
Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) (NG245) National Institute for Health and Care Excellence (NICE)
Hypothyroidism
Thyroid disease: assessment and management (NG145) National Institute for Health and Care Excellence (NICE)
Hyperthyroidism
Thyroid disease: assessment and management (NG145) National Institute for Health and Care Excellence (NICE)
Gout (gouty arthritis)
Gout: diagnosis and management (NG219) National Institute for Health and Care Excellence (NICE)
Diabetes mellitus — initial diagnosis
Type 1 diabetes in adults: diagnosis and management (NG17) National Institute for Health and Care Excellence (NICE)
Type 2 diabetes / metabolic syndrome
Type 2 diabetes in adults: management (NG28) National Institute for Health and Care Excellence (NICE)
Hypoglycemia with syncope
Low Blood Glucose (Hypoglycemia) U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Transient loss of consciousness ('blackouts') in over 16s (CG109) National Institute for Health and Care Excellence (NICE)Diabetic ketoacidosis in type 1 diabetes
Type 1 diabetes in adults: diagnosis and management (NG17) National Institute for Health and Care Excellence (NICE)
Angina pectoris
Stable angina: management (CG126) National Institute for Health and Care Excellence (NICE)
Myocardial infarction
Acute coronary syndromes (NG185) National Institute for Health and Care Excellence (NICE)
Coronary artery disease (CAD)
Stable angina: management (CG126) National Institute for Health and Care Excellence (NICE)
Acute coronary syndromes (NG185) National Institute for Health and Care Excellence (NICE)Syncope
Transient loss of consciousness ('blackouts') in over 16s (CG109) National Institute for Health and Care Excellence (NICE)
Heart failure
Chronic heart failure in adults: diagnosis and management (NG106) National Institute for Health and Care Excellence (NICE)
Acute heart failure: diagnosis and management (CG187) National Institute for Health and Care Excellence (NICE)Anemia
Guidelines for the Management of Iron Deficiency Anaemia in Adults (2021; reviewed 2026) British Society of Gastroenterology (BSG)
Abscess and sepsis after a cat bite
Suspected sepsis in people aged 16 or over: recognition, assessment and early management (NG253) National Institute for Health and Care Excellence (NICE)
Human and animal bites: antimicrobial prescribing (NG184) National Institute for Health and Care Excellence (NICE)Infective endocarditis
2023 ESC Guidelines for the management of endocarditis European Society of Cardiology (ESC)
Gastric/duodenal ulcer with upper gastrointestinal bleeding
Acute upper gastrointestinal bleeding in over 16s: management (CG141) National Institute for Health and Care Excellence (NICE)
Gastroesophageal reflux disease (GERD)
Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (CG184) National Institute for Health and Care Excellence (NICE)
Ankle fracture
Fractures (non-complex): assessment and management (NG38) National Institute for Health and Care Excellence (NICE)
Broken ankle: warning signs during recovery National Health Service (NHS)
Under Pressure: Delayed Diagnosis of Compartment Syndrome after Lower Leg Fracture (2024) Agency for Healthcare Research and Quality (AHRQ), PSNet WebM&MPatellar dislocation
Dislocated kneecap National Health Service (NHS)
Polytrauma: wrist fracture and pneumothorax
Major trauma: assessment and initial management (NG39) National Institute for Health and Care Excellence (NICE)
Fractures (non-complex): assessment and management (NG38) National Institute for Health and Care Excellence (NICE)Polytrauma with traumatic brain injury, syncope and seizure
Major trauma: assessment and initial management (NG39) National Institute for Health and Care Excellence (NICE)
Head injury: assessment and early management (NG232) National Institute for Health and Care Excellence (NICE)
Transient loss of consciousness ('blackouts') in over 16s (CG109) National Institute for Health and Care Excellence (NICE)
Epilepsies in children, young people and adults (NG217) National Institute for Health and Care Excellence (NICE)Polytrauma: Shoulder injury
Major trauma: assessment and initial management (NG39) National Institute for Health and Care Excellence (NICE)
Fractures (non-complex): assessment and management (NG38) National Institute for Health and Care Excellence (NICE)Nasal septum rupture with pneumothorax
Major trauma: assessment and initial management (NG39) National Institute for Health and Care Excellence (NICE)
Traumatic brain injury and suspected child abuse
Head injury: assessment and early management (NG232) National Institute for Health and Care Excellence (NICE)
Child abuse and neglect (NG76) National Institute for Health and Care Excellence (NICE)Intracranial hemorrhage
Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (NG128) National Institute for Health and Care Excellence (NICE)
Head injury: assessment and early management (NG232) National Institute for Health and Care Excellence (NICE)Traumatic thoracic spine fracture
Spinal injury: assessment and initial management (NG41) National Institute for Health and Care Excellence (NICE)
Transient ischemic attack (TIA)
Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (NG128) National Institute for Health and Care Excellence (NICE)
Stroke
Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (NG128) National Institute for Health and Care Excellence (NICE)
Transient global amnesia
Transiente globale Amnesie: S1-Leitlinie (2022; verlängert bis 2027) Deutsche Gesellschaft für Neurologie (DGN), AWMF 030-083
Neuroborreliosis
Lyme disease (NG95) National Institute for Health and Care Excellence (NICE)
Migraine
Headaches in over 12s: diagnosis and management (CG150) National Institute for Health and Care Excellence (NICE)
Febrile seizure
Fever in under 5s: assessment and initial management (NG143) National Institute for Health and Care Excellence (NICE)
Epilepsies in children, young people and adults (NG217) National Institute for Health and Care Excellence (NICE)Epilepsy
Epilepsies in children, young people and adults (NG217) National Institute for Health and Care Excellence (NICE)
Cervicogenic dizziness (cervical spine syndrome)
The Bárány Society position on “Cervical Dizziness” (2022) Bárány Society Classification OverSight Committee; Journal of Vestibular Research
Suspected neurological conditions: recognition and referral (NG127) National Institute for Health and Care Excellence (NICE)Vestibular neuritis
Labyrinthitis and vestibular neuritis National Health Service (NHS)
Suspected neurological conditions: recognition and referral (NG127) National Institute for Health and Care Excellence (NICE)Benign paroxysmal positional vertigo (BPPV)
Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update, 2017) American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF)
Suspected neurological conditions: recognition and referral (NG127) National Institute for Health and Care Excellence (NICE)Esophageal cancer
Oesophago-gastric cancer: assessment and management in adults (NG83) National Institute for Health and Care Excellence (NICE)
Infectious mononucleosis
Glandular fever National Health Service (NHS)
Tonsillitis
Sore throat (acute): antimicrobial prescribing (NG84) National Institute for Health and Care Excellence (NICE)
Urinary stone disease
Renal and ureteric stones: assessment and management (NG118) National Institute for Health and Care Excellence (NICE)
Benign prostatic hyperplasia
Lower urinary tract symptoms in men: management (CG97) National Institute for Health and Care Excellence (NICE)
Urinary tract infection
Urinary tract infection (lower): antimicrobial prescribing (NG109) National Institute for Health and Care Excellence (NICE)
Pyelonephritis (acute): antimicrobial prescribing (NG111) National Institute for Health and Care Excellence (NICE)Hepatitis A
Hepatitis A National Health Service (NHS)
Cholelithiasis / Cholecystitis / Common bile duct stones
Gallstone disease: diagnosis and management (CG188) National Institute for Health and Care Excellence (NICE)
Liver cirrhosis and hepatic steatosis
Cirrhosis in over 16s: assessment and management (NG50) National Institute for Health and Care Excellence (NICE)
Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49) National Institute for Health and Care Excellence (NICE)Pancreatic cancer
Pancreatic cancer in adults: diagnosis and management (NG85) National Institute for Health and Care Excellence (NICE)
Appendicitis
Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen (2021) Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV), AWMF 088-011
Crohn's disease
Crohn’s disease: management (NG129) National Institute for Health and Care Excellence (NICE)
Gastroenteritis
Diarrhoea and vomiting National Health Service (NHS)
Constipation with hypokalemia
Constipation National Health Service (NHS)
Low blood potassium (reviewed 19.05.2025) U.S. National Library of Medicine – MedlinePlusLower gastrointestinal bleeding and hemorrhoids
Diagnosis and management of acute lower gastrointestinal bleeding (2019) British Society of Gastroenterology (BSG)
Piles (haemorrhoids) National Health Service (NHS)Colon cancer
Colorectal cancer (NG151) National Institute for Health and Care Excellence (NICE)
Knee osteoarthritis (gonarthrosis)
Osteoarthritis in over 16s: diagnosis and management (NG226) National Institute for Health and Care Excellence (NICE)
Lumbar disc herniation
Low back pain and sciatica in over 16s: assessment and management (NG59) National Institute for Health and Care Excellence (NICE)
Cervical disc herniation
Suspected neurological conditions: recognition and referral (NG127) National Institute for Health and Care Excellence (NICE)
Carpal tunnel syndrome
Carpal tunnel syndrome National Health Service (NHS)
Terminology
These references cover classification wording and anatomical nomenclature; they do not establish that every glossary translation is an official definition.
- ICD-10-GM Version 2026: medizinische Diagnosebezeichnungen Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
- Terminologia Anatomica, 2nd edition (2019, IFAA approval 2020) International Federation of Associations of Anatomists (IFAA), FIPAT